Sunday 18 October 2026 Export LCTX’s income statement to Excel — free account

Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.6 million, up 53.2% from fiscal 2024. In the quarter to June 2026, revenue fell 61.3%, EPS grew 104.8%, free cash flow fell 32.4% and total debt fell 68.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.98 0.01 −1.01%

Follow LCTX

Alert me

Market cap: $250.5M
P/E: 0.0×
Fwd P/E: −17.0×
Dividend yield: —
F-score: 5/9
Altman Z: −2.91
Beneish M: −3.98
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(60.35%)	(98.51%)	(105.57%)	(158.10%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	6	5	5	5
ROA Full definition →	(32.75%)	(58.03%)	(56.27%)	(72.66%)
ROIC Full definition →	(186.79%)	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(67.96%)	(127.11%)	(126.17%)	(193.11%)
Average Days of Receivables Full definition →	22.04	19.91	22.34	4.29
Free Cash Flow per Share Full definition →	(0.10)	(0.09)	(0.08)	(0.09)
Free Cash Flow Full definition →	(24.39)	(22.59)	(19.44)	(20.87)
Capital Expenditures Full definition →	(0.57)	(0.48)	(0.52)	(0.49)
Other line items
Cash ROIC Full definition →	(22.04%)	(21.29%)	(19.61%)	(34.04%)
Accounts Receivable Turnover Full definition →	25.02	29.01	19.04	40.66
Accounts Payable Turnover Full definition →	0.00	0.00	0.02	0.05
Inventory Turnover Full definition →	—	—	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	17,952.50	7,097.22
Days of Inventory on Hand Full definition →	—	—	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	156.82%	127.54%	121.80%	119.40%
Selling, General and Administrative Expense of Revenue Full definition →	147.86%	126.44%	126.82%	166.50%
Share Based Compensation of Revenue Full definition →	38.75%	31.85%	32.65%	45.94%
Operating CF/Net income Full definition →	0.74	0.34	0.30	0.30
Depreciation/Fixed assets Full definition →	0.33	6.21	6.03	7.16
Capex/Depreciation Full definition →	(0.70)	(0.03)	(0.03)	(0.03)
Revenue per Share Full definition →	0.05	0.06	0.06	0.05
Operating CF per Share Full definition →	(0.10)	(0.09)	(0.08)	(0.09)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.04	0.03	0.04	0.05

Show all line items

Columns are period end dates

Stockrow Weekly